Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in patients with cirrhosis

SM Morris, MJ Armstrong, PN Newsome

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1220-1222
Number of pages	3
Journal	Clinical Gastroenterology and Hepatology
Volume	20
Issue number	6
Early online date	22 Sept 2021
DOIs	https://doi.org/10.1016/j.cgh.2021.09.023
Publication status	Published - Jun 2022

Access to Document

@article{640184f0fda349c188f3a4e06de63d16,

title = "Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in patients with cirrhosis",

author = "SM Morris and MJ Armstrong and PN Newsome",

year = "2022",

month = jun,

doi = "10.1016/j.cgh.2021.09.023",

language = "English",

volume = "20",

pages = "1220--1222",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in patients with cirrhosis

AU - Morris, SM

AU - Armstrong, MJ

AU - Newsome, PN

PY - 2022/6

Y1 - 2022/6

UR - http://europepmc.org/abstract/med/34560279

U2 - 10.1016/j.cgh.2021.09.023

DO - 10.1016/j.cgh.2021.09.023

M3 - Editorial

C2 - 34560279

SN - 1542-3565

VL - 20

SP - 1220

EP - 1222

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 6

ER -